Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, BMS, Chiesi, Claritas, Daiichi, Immunitybio, Incyte, Johnson & Johnson, Junshi, MBX, Nanosonics, PMV, Precision, Protalix, Sangamo, Savara.
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Actuate, Baymedica, DT-Axis, Eledon, Etcembly, Fujitsu, Galecto, Inmed, Kuva Labs, Kyron.bio, Lisata, Newcelx, Servier, Zelluna.
Biopharma and med-tech companies raising money in public or private financings, including: AN2, Defence, Invea, Korro, Lyell, Relmada, SS Innovations, Telo Genomics.
Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Accord, Asieris, Claritas, Drug Farm, Foresee, Glenmark, Nxera, Hua Medicine, Innocare, Innovent, Meiji, Pepgen, Pharmaessentia, Protagonist, Sanofi, Sciwind, Sumitomo, Takeda.
Biopharma and med-tech happenings in Asia-Pacific, including deals and partnerships, and other news in brief: Bcworld, Beam, Bio Palette, Celltype, Congruence, Daiichi Sankyo, Gaia, Grünenthal, GSK, Immunis, Ono, Rapport, Rapt, Senhwa, Shanghai Jeyou, Sinopia, Takeda, Tenacia, Toray.
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Accord, Claritas, Foresee, Johnson & Johnson, Lifevac, Royal Philips, Sciwind, Soterix, Sumitomo.